Johnson and Johnson Vision has announced the discontinuation of several prescription ranges for it's popular Acuvue Oasys for Astigmatism brand of lenses. Please note, the Acuvue Oasys for Astigmatism contact lens is still available in the majority of the power ranges; only specific prescriptions are affected. In a letter to practitioners across the United States, Johnson and Johnson Vision cited the decision was based on a number of factors affecting industries around the world in 2022: short staffing at their distribution and contact center, supply chain issues, and increased product demand. The Acuvue Oasys MAX 1 Day brand of lenses recently launched in summer of 2022. In order to divert resources to the most needed prescription ranges (the company serves 43 million people globally with their Acuvue brand contact lens products), the discontinued parameters listed below were chosen because they were the least ordered prescriptions currently offered by the company. 

The following powers are no longer available: